All In MedTech

Device Trial Radar · NCT04974515

Adherence to Electrical Glossal In Situ Stimulation for Sleep Apnea (AEGIS Study)

Adherence to Electrical Glossal In Situ Stimulation for Sleep Apnea

Last checked: Nov 20, 2026Latest source record: Oct 16, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

40

Actual

Start

Aug 17, 2021

Primary completion

Oct 31, 2022

Study completion Oct 31, 2022

Sponsor

Lead sponsor
University of MiamiAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jul 23, 2021

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Other
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this research is to assess how well people with mild obstructive sleep apnea (OSA) adhere to the eXciteOSA device and specifically examine whether adherence of the device is different with low versus high electrical stimulation. In addition, this research study will assess how well the device affects mild sleep apnea and if it improves sleepiness and quality of life.

Conditions

  • Obstructive Sleep Apnea

Interventions

  • eXciteOSADevice

    eXciteOSA is a device for improving genioglossus endurance through electrical stimulation

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mean Number of Days Device Was UsedTime frame: Up to 6 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • University of Miami

    Miami, Florida

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.